TTrialPathMatch Me to Trials
← Back to trials
RecruitingHealthcare ProvidersPostpartum

Impact of Vaccine Funding by the National Health Insurance on Vaccination Coverage Among Patients Targeted by Current Vaccination Recommendations and Followed in Outpatient Consultations

Eligible age

18+ yrs

Accepts

All genders

Locations

0 states

Healthy volunteers

Yes

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The objective of our study is to evaluate the impact of vaccine funding for patients seen in outpatient consultations within four healthcare institutions in the Ile-de-France region in France, made possible through the establishment of a tripartite agreement between the hospital group, the Île-de-France Regional Health Agency (ARS IDF), and the Primary Health Insurance Fund (CPAM).

Sponsor: Assistance Publique - Hôpitaux de Paris

You may qualify if…

  • ✓ For patients:
  • ✓ 1. For the assessment of pneumococcal coverage among patients eligible for this vaccination:
  • ✓ Individuals aged 18 years or older,
  • ✓ Individuals followed in outpatient consultations within a department and healthcare institution participating in the project;
  • ✓ Individuals eligible for pneumococcal vaccination against according to current French recommendations,
  • ✓ Individuals meeting the eligibility conditions and receiving care under long-term illness coverage (ALD) or benefiting from complementary universal health coverage (C2S) or state medical aid (AME).
  • ✓ 2. For the assessment of pertussis vaccination among pregnant women:
  • ✓ Women aged 18 years or older,

You may not qualify if…

  • ✕ Individuals seen in settings other than outpatient consultations (day hospital, week hospital, conventional hospitalization, International Vaccination Center).

Source: ClinicalTrials.gov · NCT07243236 · last updated 2026-04-08